A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma to the Brain (Break MB)
This study is ongoing, but not recruiting participants.
Sponsor:
GlaxoSmithKline
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT01266967
First received: December 2, 2010
Last updated: November 15, 2012
Last verified: October 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | November 2012 |
| Primary Completion Date: | November 2011 (Final data collection date for primary outcome measure) |
| Certification or Request for Extension to Delay Results Received: | June 7, 2012 |